MELISSA JENKINS: Open Payments
NPI 1902390289 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 17 payments from 13 companies in 2025. Trend: 2023 $5,658 · 2024 $1,201 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $239 |
| Janssen Biotech, Inc. | 2 | $45 |
| Celgene Corporation | 2 | $44 |
| Tempus AI, Inc | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| ABBVIE INC. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| TAIHO ONCOLOGY, INC. | 1 | $23 |
Products named: ELREXFIO, ERLEADA, REBLOZYL, XT CDX, SCEMBLIX, VENCLEXTA, IBRANCE, KEYTRUDA.
Industry payments across KY — which companies pay providers there.
